Is cannabis a gateway to hard drugs?

Empirical Economics

Volumn 38, Issue 3, 2010, Pages 583-603

  Melberg, Hans Olav ^a   Jones, Andrew M ^b   Bretteville Jensen, Anne Line ^c  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF YORK   (United Kingdom)

^c NORWEGIAN INSTITUTE FOR ALCOHOL AND DRUG RESEARCH   (Norway)

Author keywords

Duration analysis; Gateway hypothesis; Illicit drugs; Latent class models

Indexed keywords

DRUG USER; HYPOTHESIS TESTING; MODELING; RISK ASSESSMENT;

CANNABIS;

EID: 77951207101     PISSN: 03777332     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00181-009-0280-z     Document Type: Article

References (25)

1. Abbring JH, van den Berg G (2003) The non-parametric identification of treatment effects in duration models. Econometrica 71: 1491-1517.
2. Ainslie G (1992) Picoeconomics. Cambridge University Press, Cambridge.
3. Beenstock M, Rahav G (2002) Testing gateway theory: do cigarette prices affect illicit drug use. J Health Econ 21: 679-698.
4. Bretteville-Jensen AL, Biørn E (2003) Heroin consumption, prices and addiction: evidence from self-reported panel data. Scand J Econ 105: 661-679.
5. Bretteville-Jensen AL, Melberg HO, Jones AM (2008) Sequential patterns of drug use initiation-can we believe in the gateway theory? BE J Econ Anal Policy 8 (Contributions), Article 1.
6. Deb P, Trivedi PK (1997) Demand for medical care by the elderly: a finite mixture approach. J Appl Econ 12: 313-336.
7. DeSimone J (1998) Is Marijuana a gateway drug. East Econ J 24: 149-164.
8. Fergusson DM, Horwood LJ (2000) Does Cannabis use encourage other forms of illicit drug use. Addiction 95: 505-520.
9. Fergusson DM, Boden JM, Horwood LJ (2006) Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction 101: 556-569.
10. Gaure S, Røed K, Zhang T (2007) Time and causality: a Monte Carlo assessment of the timing-of-events approach. J Econom 141: 1159-1195.
11. Golub A, LaBouvie E, Johnson BD (2000) Response reliability and the study of adolescent substance use progression. J Drug Issues 30: 103-118.
12. Heckman JJ, Honorè BE (1989) The identifiability of the competing risks model. Biometrica 76: 325-330.
13. Heckman JJ, Navarro S (2007) Dynamic discrete choice and dynamic treatment effects. J Econom 136: 341-396.
14. Horverak Ø (2006) Norwegian drinking pattern-undergoing change? In: Bryhni A (ed) Alcohol and drugs in Norway, Annual report, Norwegian Institute for Alcohol and Drug, Oslo, pp 28-39.
15. Jenkins S (1995) Easy estimation methods for discrete-time duration models. Oxf Bull Econ Stat 57: 129-138.
16. Kandel DB (1975) Stages in adolescent involvement in drug use. Science 190: 912-914.
17. Lancaster T (1990) The econometric analysis of transition data. Cambridge University Press, Cambridge.
18. Lyons MJ, Toomey R, Meyer JM, Green AI, Eisen SA, Goldberg J, True WR, Tsuang MT (1997) How do genes influence Marijuana use? The role of subjective effects. Addiction 92: 409-417.
19. Ng SK, Krishnan T, McLachlan GJ (1995) The EM algorithm. In: Gentle JE, Härdle W, Mori Y(eds) Handbook of computational statistics, Springer, Heidelberg, pp 137-168.
20. Pacula RL (1998) Does increasing beer tax reduce Marijuana consumption. J Health Econ 17: 557-585.
21. Pedersen W (2008) Hasjbruk blant unge (Young people's cannabis use). Norwegian Med J 128(16): 1825-1828.
22. Pudney S (2003) The road to ruin? Sequences of initiation to drug use and crime in Britain. Econ J 113: 182-198.
23. van Ours JC (2003) Is Cannabis a stepping-stone for Cocaine. J Health Econ 22: 539-554.
24. Williams J (2004) The effect of price and policy on Marijuana use: what can be learned from the Australian experience. Health Econ 13: 123-137.
25. Yamaguchi K, Kandel DB (1984) Patterns of drug use from adolescence to young adulthood: III Predictors of progression. Am J Public Health 74: 673-681.